Publication: Antiproliferative effect of α-mangostin on canine osteosarcoma cells
| dc.contributor.author | Krajarng A. | |
| dc.contributor.author | Nilwarankoon S. | |
| dc.contributor.author | Suksamrarn S. | |
| dc.contributor.author | Watanapokasin R. | |
| dc.date.accessioned | 2021-04-05T03:33:54Z | |
| dc.date.available | 2021-04-05T03:33:54Z | |
| dc.date.issued | 2012 | |
| dc.date.issuedBE | 2555 | |
| dc.description.abstract | Osteosarcoma is the most frequently diagnosed primary bone tumor in dog. Since chemotherapeutics are quite limited due to high cost and severe toxicity, therefore, the ultimate goal is to discover cost-effective therapeutics with less toxicity. We have studied the effect of α-mangostin, a xanthone derivative isolated from pericarp of mangosteen (Garcinia mangostana Linn.) in canine osteosarcoma, D-17 cells. The results showed that α-mangostin induced antiproliferation with IC50 at 15μg/ml. Hoechst 33342 nuclear staining and nucleosomal DNA-gel electrophoresis revealed that α-mangostin could induce nuclear condensation and fragmentation, typically seen in apoptosis. Cell cycle analysis demonstrated that α-mangostin induced sub-G1 peak. In addition, α-mangostin also induced membrane flipping of the phosphatidylserine and the loss of mitochondrial membrane potential in D-17 cells. In conclusion, α-mangostin, induced apoptotic cell death against canine osteosarcoma D-17 cells, could be a potential candidate for preventive and therapeutic application for bone cancer treatment in dogs. © 2012 Elsevier Ltd. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Research in Veterinary Science. Vol 93, No.2 (2012), p.788-794 | |
| dc.identifier.doi | 10.1016/j.rvsc.2012.01.015 | |
| dc.identifier.issn | 345288 | |
| dc.identifier.other | 2-s2.0-84863108518 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/6951 | |
| dc.rights.holder | มหาวิทยาลัยศรีนครินทรวิโรฒ | |
| dc.subject.other | Alpha mangostin | |
| dc.subject.other | Antineoplastic agent | |
| dc.subject.other | DNA | |
| dc.subject.other | Hoe 33342 | |
| dc.subject.other | Phosphatidylserine | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Xanthone derivative | |
| dc.subject.other | Animal cell | |
| dc.subject.other | Antiproliferative activity | |
| dc.subject.other | Apoptosis | |
| dc.subject.other | Article | |
| dc.subject.other | Cell cycle G1 phase | |
| dc.subject.other | Cell membrane | |
| dc.subject.other | Cell nucleus fragmentation | |
| dc.subject.other | Cell strain D 17 | |
| dc.subject.other | Cellular parameters | |
| dc.subject.other | Concentration response | |
| dc.subject.other | Controlled study | |
| dc.subject.other | DNA fragmentation | |
| dc.subject.other | Dog | |
| dc.subject.other | Drug cytotoxicity | |
| dc.subject.other | Drug isolation | |
| dc.subject.other | Flow cytometry | |
| dc.subject.other | Garcinia mangostana | |
| dc.subject.other | Gel electrophoresis | |
| dc.subject.other | IC 50 | |
| dc.subject.other | Mitochondrial membrane potential | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Nuclear condensation | |
| dc.subject.other | Nucleosome | |
| dc.subject.other | Osteosarcoma | |
| dc.subject.other | Osteosarcoma cell | |
| dc.subject.other | Pericarp | |
| dc.subject.other | Phospholipid metabolism | |
| dc.subject.other | Staining | |
| dc.subject.other | Animals | |
| dc.subject.other | Antineoplastic Agents, Phytogenic | |
| dc.subject.other | Cell Cycle | |
| dc.subject.other | Cell Line, Tumor | |
| dc.subject.other | Cell Proliferation | |
| dc.subject.other | Cell Survival | |
| dc.subject.other | Dogs | |
| dc.subject.other | Garcinia mangostana | |
| dc.subject.other | Osteosarcoma | |
| dc.subject.other | Xanthones | |
| dc.subject.other | Canis familiaris | |
| dc.subject.other | Garcinia mangostana | |
| dc.title | Antiproliferative effect of α-mangostin on canine osteosarcoma cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863108518&doi=10.1016%2fj.rvsc.2012.01.015&partnerID=40&md5=5ce11b57663ec1f4cc4b389c5adeb1ce |
